Sun Pharma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 90.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 40.05 Cr
as on 09-07-2024
- Company Age 28 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 16.58%
(FY 2023)
- Profit -147.27%
(FY 2023)
- Ebitda 9.04%
(FY 2023)
- Net Worth -5.34%
(FY 2023)
- Total Assets -5.03%
(FY 2023)
About Sun Pharma Laboratories
The Corporate was formerly known as Sun Resins And Polymers Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 90.00 Cr and a paid-up capital of Rs 40.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sun Pharma Laboratories Limited India are Kirti Ganorkar as Ceo, Chinnadharavaram Muralidharan as Cfo, and Meetal Sampat as Company Secretary. Gautam Doshi, Sudhir Valia, Kalyanasundaram Subramanian, and Two other members serve as directors at the Company.
- CIN/LLPIN
U25200GJ1997PLC133846
- Company No.
240268
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jan 1997
- Date of AGM
31 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sun Pharma Laboratories Limited offer?
Sun Pharma Laboratories Limited offers a wide range of products and services, including Skin Care, Sunscreen Products.
Who are the key members and board of directors at Sun Pharma Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kirti Ganorkar  | CEO | 04-Jul-2019 | Current |
| Chinnadharavaram Muralidharan | CFO | 19-Jun-2017 | Current |
| Meetal Sampat | Company Secretary | 27-May-2022 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakeshchandra Sinha | Additional Director | 24-Apr-2024 | Current |
| Gautam Doshi | Director | 20-Oct-2021 | Current |
| Sudhir Valia | Director | 30-Oct-2012 | Current |
Kalyanasundaram Subramanian  | Director | 13-Feb-2017 | Current |
| Priti Savla | Director | 31-Oct-2022 | Current |
Financial Performance of Sun Pharma Laboratories.
Sun Pharma Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.58% increase. The company also saw a substantial fall in profitability, with a 147.27% decrease in profit. The company's net worth dipped by a decrease of 5.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sun Pharma Laboratories?
In 2023, Sun Pharma Laboratories had a promoter holding of 100.00%. The company had 3 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sun Pharmaceutical Industries LimitedActive 31 years 10 monthsGautam Doshi, Sudhir Valia and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sun Pharma Laboratories?
Sun Pharma Laboratories has a workforce of 11381 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun Pharma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
